RxDoctor Payments DataLook up a doctor →

Mousab Tabbaa, MD

Gastroenterology · Westlake, OHNPI 1184642050

Payments from drug & device makers

$1,421,060in general payments, 2019–2025

Across 446 payments — averaging $3186.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Madrigal Pharmaceuticals$259K
  • Genentech, Inc.$254K
  • GSK$254K
  • Braintree Laboratories, Inc.$233K
  • Astrazeneca UK Limited$144K
  • F. Hoffmann-la Roche AG$56K
  • plus $221K from 39 others
$1,598in research payments, 2019–2025

Across 2 payments — averaging $799.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$2K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,421,060 in reported general payments places this provider in the 95th percentile of 657 gastroenterology providers in Ohio.

See all gastroenterology providers in Ohio

Medicare billing

Part B allowed, 2024
$840,238
Medicare patients
637
Services billed
41,109

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Westlake

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →